4-Butylresorcinol
![]() | |
Names | |
---|---|
Preferred IUPAC name 4-Butylbenzene-1,3-diol | |
Other names Rucinol, 4-n-Butylresorcinol | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEBI |
|
ChEMBL |
|
ChemSpider |
|
ECHA InfoCard | 100.126.948 ![]() |
EC Number |
|
KEGG |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C10H14O2 |
Molar mass | 166.220 g·mol−1 |
Hazards | |
GHS labelling: | |
Pictograms | ![]() ![]() |
Warning | |
Hazard statements | H302, H315, H319, H400 |
Precautionary statements | P264, P270, P273, P280, P301+P312, P302+P352, P305+P351+P338, P321, P330, P332+P313, P337+P313, P362, P391, P501 |
Safety data sheet (SDS) | [1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references |
Chemical compound
4-Butylresorcinol, sometimes called 4-n-butylresorcinol, is a chemical used to treat hyperpigmentation of the epidermis. Hyperpigmentation is believed to be related to the enzyme tyrosinase which produces melanin. Among several chemicals known to inhibit tyrosinase production, such as hydroquinone, arbutin, and kojic acid, 4-butylresorcinol has been found to be the most powerful inhibitor by a wide margin.[1] 4-Butylresorcinol can be used in the synthesis of Tetrahydrocannabutol.
References
- ^ "Hydroquinones". Phenols—Advances in Research and Application: 2013 Edition. Scholastic. 2013. p. 76.